PuSH - Publikationsserver des Helmholtz Zentrums München

Amar, Y.* ; Schneider, E. ; Köberle, M.* ; Seeholzer, T. ; Musiol, S. ; Hölge, I.M.* ; Gschwendtner, S. ; Krappmann, D. ; Steiger, K.* ; Biedermann, T.* ; Schmidt-Weber, C.B. ; Alessandrini, F.

Microbial dysbiosis in a mouse model of atopic dermatitis mimics shifts in human microbiome and correlates with the key pro-inflammatory cytokines IL-4, IL-33 and TSLP.

J. Eur. Acad. Dermatol. Venereol. 36, 705-716 (2022)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Cutaneous bacterial dysbiosis is a characteristic hallmark of atopic dermatitis (AD) and it decisively influences the severity of the disease. Despite this, frequently used murine models of AD have not been characterized regarding the changes in skin microbiome communities. OBJECTIVE: To analyze the skin microbiome of two frequently used murine models for AD for assessing their applicability in translational research. METHODS: AD was induced in mice by topical application of calcipotriol, or oxazolone. Following comparable elicitation of AD-like dermatitis, including IgE induction, the skin microbial communities were analyzed and compared with human AD. RESULTS: We detected critical differences in the microbiota composition of diseased skin. In contrast to calcipotriol treatment, application of oxazolone induced significant changes of the cutaneous microbiota and a drastic drop of bacterial richness. Furthermore, an expansion of Staphylococci, particularly S. xylosus was observed in the oxazolone group, also displaying positive correlations with AD key markers including pH, TEWL, IL-4, TSLP and IL-33. CONCLUSIONS: In this article we show that i) the model of choice to investigate AD needs to be characterized for the cutaneous microbiota if applicable and ii) the oxazolone-mediated mixed Th1-Th2 immune response triggers microbiota-induced alterations which share similarities to dysbiosis in human AD and represents therefore a suitable model for translational research on AD if alterations of the microbiome are in the focus of the investigation.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
9.228
0.000
4
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Microbiome ; Atopic Dermatitis ; Mouse Models; Thymic Stromal Lymphopoietin; Skin Microbiome; Stratum-corneum; Antimicrobial Peptides; Barrier Disruption; Water-loss; Expression; Mice; Keratinocytes; Ph
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 0926-9959
e-ISSN 1468-3083
Quellenangaben Band: 36, Heft: 5, Seiten: 705-716 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
Research Unit Signaling and Translation (SAT)
Research Unit Comparative Microbiome Analysis (COMI)
POF Topic(s) 30202 - Environmental Health
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Allergy
Enabling and Novel Technologies
Environmental Sciences
PSP-Element(e) G-505400-001
G-509800-002
G-504700-002
Förderungen Deutsche Forschungsgemeinschaft
Federal Ministry of Food and Agriculture (BMEL)
Scopus ID 85123501350
PubMed ID 35015907
Erfassungsdatum 2022-05-30